6.5976
3.69%
0.2376
Schlusskurs vom Vortag:
$6.36
Offen:
$6.46
24-Stunden-Volumen:
570.11K
Relative Volume:
0.41
Marktkapitalisierung:
$369.01M
Einnahmen:
$217.11M
Nettoeinkommen (Verlust:
$-651.19M
KGV:
-9.2924
EPS:
-0.71
Netto-Cashflow:
$-387.26M
1W Leistung:
-9.78%
1M Leistung:
-26.07%
6M Leistung:
-77.45%
1J Leistung:
-88.47%
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Firmenname
Ginkgo Bioworks Holdings Inc
Sektor
Branche
Telefon
(877) 442-5362
Adresse
27 DRYDOCK AVENUE, BOSTON
Vergleichen Sie DNA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
DNA | 6.58 | 369.01M | 217.11M | -651.19M | -387.26M | -0.71 |
VRTX | 449.14 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 748.83 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 587.39 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 248.01 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 106.99 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-05-15 | Herabstufung | BTIG Research | Neutral → Sell |
2024-05-10 | Herabstufung | William Blair | Mkt Perform → Underperform |
2023-11-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2023-11-09 | Herabstufung | BTIG Research | Buy → Neutral |
2023-06-02 | Herabstufung | Goldman | Neutral → Sell |
2023-05-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
2022-11-29 | Eingeleitet | Berenberg | Buy |
2022-10-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
2022-05-18 | Herabstufung | BofA Securities | Neutral → Underperform |
2022-03-02 | Fortgesetzt | Cowen | Outperform |
2022-02-23 | Eingeleitet | Goldman | Neutral |
2022-02-01 | Eingeleitet | BofA Securities | Neutral |
2022-01-28 | Eingeleitet | BofA Securities | Buy |
2022-01-07 | Eingeleitet | BTIG Research | Buy |
2021-11-29 | Eingeleitet | Jefferies | Buy |
2021-10-13 | Eingeleitet | Raymond James | Outperform |
2021-10-12 | Eingeleitet | William Blair | Outperform |
2021-09-20 | Eingeleitet | HSBC Securities | Buy |
Alle ansehen
Ginkgo Bioworks Holdings Inc Aktie (DNA) Neueste Nachrichten
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by Tao Capital Management LP - MarketBeat
US Bancorp DE Sells 183,450 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
How To Trade (DNA) - Stock Traders Daily
Ginkgo Bioworks: Unproven Transition But 2025 Is Looking Better (NYSE:DNA) - Seeking Alpha
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Short Interest Update - MarketBeat
GSA Capital Partners LLP Has $979,000 Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Just Released Its Third-Quarter Earnings: Here's What Analysts Think - Simply Wall St
Ginkgo Bioworks Holdings Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Ginkgo cancels move to new South Boston lab, exits Cambridge office - MassLive.com
Ginkgo Bioworks Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q3 2024 Earnings Call Transcript - MSN
Ginkgo Bioworks: Not Enough Progress (NYSE:DNA) - Seeking Alpha
Baillie Gifford & Co. Sells 131,067,285 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Reports Q3 Growth and Strategic Deals - TipRanks
Ginkgo nixes move to South Boston lab, will exit Cambridge sites. Here's what it means - NBC Boston
Ginkgo nixes move to South Boston lab, will exit Cambridge sites - The Business Journals
Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q3 Loss, Tops Revenue Estimates - MSN
Ginkgo Bioworks Reports Third Quarter 2024 Financial Results – Company Announcement - Financial Times
Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing - Marketscreener.com
Ginkgo Bioworks Secures $9M Milestone Payment from Merck Partnership Breakthrough | DNA Stock News - StockTitan
Insights into Ginkgo Bioworks Holdings's Upcoming Earnings - Benzinga
Ginkgo Bioworks chief accounting officer sells $2,522 in stock - Investing.com India
Ginkgo Bioworks chief accounting officer sells $2,522 in stock By Investing.com - Investing.com Australia
(DNA) On The My Stocks Page - Stock Traders Daily
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Receives Consensus Recommendation of "Reduce" from Brokerages - MarketBeat
Ginkgo Bioworks (DNA) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
BTIG Downgrades Ginkgo Bioworks Holdings Inc(DNA) - MSN
Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market - MSN
Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation - BioSpace
Ginkgo Bioworks (DNA) Sets Q3 2024 Earnings Call for November 12 | DNA Stock News - StockTitan
Dutch ingredients Firm Vivici Partners With Ginkgo Bioworks For Alternative Protein Development - MSN
Vanguard Group Inc's Strategic Reduction in Ginkgo Bioworks Holdings Inc - GuruFocus.com
With 48% ownership, Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has piqued the interest of institutional investors - Yahoo Finance
Ginkgo Bioworks (DNA): A Leader in Cell Programming and Genetic Diagnostics - Insider Monkey
10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds - Insider Monkey
Ginkgo Bioworks Holdings, Inc. (DNA) Outpaces Stock Market Gains: What You Should Know - MSN
Forbes J M & Co. LLP Invests $1.02 Million in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
PFG Investments LLC Invests $1.54 Million in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Major Boston biotech company begins layoffs this week - MSN
Ginkgo Bioworks (NYSE:DNA) Shares Up 5%Here's What Happened - MarketBeat
Equitec Proprietary Markets LLC Has $99,000 Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Sees Significant Growth in Short Interest - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Trading 5.9% HigherStill a Buy? - MarketBeat
Exchange Traded Concepts LLC Has $2.99 Million Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now? - MSN
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by Squarepoint Ops LLC - MarketBeat
Algert Global LLC Takes $36,000 Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Receives $4.16 Consensus Target Price from Analysts - MarketBeat
Ginkgo Bioworks Holdings Inc (DNA) Q2 2024 Earnings Call Highlights: Strategic Restructuring ... By GuruFocus - Investing.com Canada
Ginkgo Bioworks executive sells over $10k in company stock By Investing.com - Investing.com Australia
Ginkgo Bioworks exec sells over $2500 in stock By Investing.com - Investing.com Canada
Finanzdaten der Ginkgo Bioworks Holdings Inc-Aktie (DNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):